Third Coast Therapeutics, Inc. — Form D
Third Coast Therapeutics, Inc. of EVANSTON, IL, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-24. The offering totals $600K, of which $35K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-09-24
- Form: D
- Accession: 0001706603-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $35K
- Remaining: $565K
- Minimum investment: $5K
- Investors: 2
- Date of first sale: 2018-09-18
- Revenue range: No Revenues
- SEC file number: 021-322040
Issuer
- Name: Third Coast Therapeutics, Inc.
- CIK: 0001706603
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 600 DAVIS STREET, EVANSTON, IL, 60201-4488
- Phone: 6087725878
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Raymond Bergan | Director | Portland, OR |
| Joseph Luminiello | Director | Tower Lakes, IL |
| Karl Scheidt | Director | Evanston, IL |
| Joseph Luminiello | Executive Officer | Tower Lakes, IL |
Other filings by this issuer (1)
More